The global sinus dilation device market size is estimated to reach USD 4.6 billion by 2028, registering a CAGR of 11.0%, according to a new report by Grand View Research, Inc. Changes in lifestyle, increasing cases of obesity, and a resultant rise in the incidence of sinus-related conditions are the major factors contributing to the market growth. The introduction of technologically advanced devices is also one of the key factors boosting market growth. Major market players are focusing on R&D activities to introduce minimally invasive procedures creating a positive impact on the adoption of MIS procedures.
Some of the inventions in the market related to endoscopic approaches include a nasal endoscope, rhinoscopes, and balloon sinus dilation devices. An increase in medical reimbursements across major markets is likely to fuel the market growth. Rising adoption of health insurance and growing per capita expenditure coupled in developed as well as developing countries is predicted to augment the market growth.
In November 2017, Entellus Medical, Inc. announced that Anthem, Inc., an American health insurance company, provided insurance coverage for Balloon Sinus Dilation (BSD) used in the treatment of recurrent acute sinusitis and chronic sinusitis. Anthem, Inc. is a member of the Blue Cross Blue Shield Association, the second-largest health benefits plan provider that covers around 40 million people in the U.S. Other major health insurance companies providing coverage for standalone BSD are Medicare, Aetna, Cigna, TRICARE, Humana, Health Net, Kaiser, and United Healthcare.
Request a free sample copy or view report summary: Sinus Dilation Device Market Report
The BSD devices segment held the largest revenue share in 2020 and will retain the leading position throughout the forecast period
The hybrid procedure segment led the market in 2020 and is also expected to register the fastest CAGR during the forecast period
Hybrid procedures are useful and effective in adults as well as pediatrics for the treatment of frontal chronic rhinosinusitis
The adult application segment held the largest market share in 2020 owing to the high prevalence of chronic rhinitis among the adult population
The hospitals end-use segment accounted for the highest share in 2020 owing to advanced infrastructure and an increasing number of patient visits in hospitals as compared to other healthcare facilities
North America is projected to account for the largest market share by 2028 due to the high adoption of novel technologies by ENT surgeons as well as other healthcare professionals in the region
Grand View Research has segmented the global sinus dilation device market on the basis of product, procedure, application, end use, and region:
Sinus Dilation Devices Product Outlook (Revenue, USD Million, 2016 - 2028)
Balloon Sinus Dilation Devices
Functional Endoscopic Sinus Surgery (FESS) Instruments Set
Sinus Dilation Devices Procedure Outlook (Revenue, USD Million, 2016 - 2028)
Sinus Dilation Devices Application Outlook (Revenue, USD Million, 2016 - 2028)
Sinus Dilation Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)
Ambulatory Surgical Centers (ASCs)
Sinus Dilation Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)
Middle East & Africa
List of Key Players of Sinus Dilation Device Market
Smith & Nephew
This report has a service guarantee. We stand by our report quality.
Your transaction & personal information is safe and secure.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
Avail customized purchase options to meet your research needs:
"The quality of research they have done for us has been excellent..."